Status:

COMPLETED

Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial

Lead Sponsor:

University Hospital, Basel, Switzerland

Collaborating Sponsors:

Kantonsspital Aarau

Kantonsspital Liestal

Conditions:

Community-acquired Pneumonia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Background: An intact hypothalami-pituitary-adrenal (HPA) axis with an effective intracellular anti-inflammatory activity of glucocorticoids is indispensable for host survival during stress upon expos...

Eligibility Criteria

Inclusion

  • Patients 18 years of age or older admitted for hospitalization from the community or a nursing home with CAP.
  • CAP will be defined by a new infiltrate on chest radiograph and the presence of one or several of the following acute respiratory signs or symptoms:
  • cough
  • sputum production
  • dyspnea
  • core body temperature \>38.0° C
  • auscultatory findings of abnormal breath sounds and rales
  • leukocyte count \>10 or \<4 x 109 cells L-1 (1)

Exclusion

  • Patients or family members unable to give written informed consent, e.g. with severe dementia.
  • Patients with active intravenous drug use.
  • Severe immunosuppression (e.g. patients infected with human immunodeficiency virus infection and a CD4 count below 350 x 109/L, patients on immunosuppressive therapy after solid organ transplantation and neutropenic patients with neutrophil count \< 500 x 109/L and patients under chemotherapy with neutrophils 500-1000 x 109/L with an expected decrease to values \< 500 x 109/L); patients with cystic fibrosis as well as patients with active tuberculosis.
  • Patients with acute burn injury
  • Patients with acute gastrointestinal bleeding within 3 months of the current hospitalization
  • Patients with an acute concomitant condition requiring more than 0.5mg/kg/d prednisone equivalent
  • Pregnancy or breast feeding
  • Patients with known adrenal insufficiency

Key Trial Info

Start Date :

December 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT00973154

Start Date

December 1 2009

End Date

December 1 2014

Last Update

April 21 2015

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Medizinische Klinik, Kantonsspital Liestal

Liestal, Basel-Landschaft, Switzerland, 4410

2

Medicine Interne, Hôpital du Jura, site de Delémont

Delémont, Canton of Jura, Switzerland, 2800

3

Kantonsspital Aarau

Aarau, Switzerland

4

University Hospital Basel

Basel, Switzerland, 4031